Daniel Courtade
Cardiovascular Disease · Edgewood, KYNPI 1811980683
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.5% of the total across 179 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by Johnson & Johnson at 44.7% of the total. Reporting peaked in 2021 at $1,279 and has fallen 94.7% since, to $68 in 2023. That places this record below the midpoint for cardiovascular disease clinicians in KY, where the typical reported total is $2,503.
Across 179 payments — averaging $15.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- Novartis$284
- AstraZeneca$206
- Actelion Pharmaceuticals US, Inc.$154
- Shockwave Medical, Inc$147
- Amgen$138
- plus $627 from 17 others
What the payments were for
- Food & beverage$2,71496%
- Education$994%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 104 | $1,257 |
| Novartis | 17 | $284 |
| AstraZeneca | 7 | $206 |
| Actelion Pharmaceuticals US, Inc. | 7 | $154 |
| Shockwave Medical, Inc | 1 | $147 |
| Amgen | 10 | $138 |
| Abbott | 2 | $127 |
| Sanofi-aventis U.S. LLC | 5 | $82 |
| Pfizer | 4 | $49 |
| Abiomed | 1 | $44 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $39 |
| Boehringer Ingelheim | 2 | $38 |
| Vifor Pharma, Inc. | 2 | $37 |
| Boston Scientific | 2 | $35 |
| Biosense Webster, Inc. | 1 | $34 |
| Chiesi USA, Inc. | 2 | $27 |
| Lundbeck LLC | 2 | $26 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Amarin Pharma, Inc. | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| Regeneron Healthcare Solutions, Inc. | 1 | $11 |
| Merck | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Vascular Lithotripsy$147
- CARDIOMEMS$110
How this compares
$2,813 in reported general payments places this provider in the 50th percentile of 258 cardiovascular disease providers in Kentucky.
Other cardiovascular disease in Edgewood
- Stephen SchutzmanEdgewood$17K
- Kevin MillerEdgewood$10K
- Darryl DiasEdgewood$7K
- Amir PirachaLouisville$530K
- Dinesh KalraLouisville$316K
- William SkinnerLexington$312K
- Prabodh MehtaElizabethtown$133K
- John HarrisLouisville$129K
- David MoliternoLexington$115K
- Rohan SamsonLouisville$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.